Christoffer Rosenblad is the CEO at XVIVO. As CEO, Christoffer leads the company toward its vision that nobody should die waiting for a new organ and helps clinicians and researchers push the boundaries of organ transplantation, making it more accessible and reliable for people around the world. Over the past decade, Christoffer has served as COO, CFO, and Head of XVIVO North America, playing key roles in shaping its strategy, driving global growth, and nurturing a culture of innovation rooted in collaboration and integrity.
Machine perfusion extends the viability of organs outside the body by circulating oxygen and nutrients through a specialized solution. This means organs can travel greater distances, medical teams have more time to make thoughtful decisions and patients have a better chance of getting a match.